On Tuesday, Immunic Inc (NASDAQ: IMUX) opened higher 6.84% from the last session, before settling in for the closing price of $1.17. Price fluctuations for IMUX have ranged from $0.92 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 54.22% at the time writing. With a float of $87.36 million, this company’s outstanding shares have now reached $90.08 million.
Let’s determine the extent of company efficiency that accounts for 77 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immunic Inc is 3.02%, while institutional ownership is 54.84%. The most recent insider transaction that took place on Nov 12 ’24, was worth 100,369. In this transaction Director of this company bought 87,300 shares at a rate of $1.15, taking the stock ownership to the 87,300 shares.
Immunic Inc (IMUX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.57% during the next five years compared to 31.12% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Check out the current performance indicators for Immunic Inc (IMUX). In the past quarter, the stock posted a quick ratio of 2.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.78 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Looking closely at Immunic Inc (NASDAQ: IMUX), its last 5-days average volume was 0.56 million, which is a drop from its year-to-date volume of 0.87 million. As of the previous 9 days, the stock’s Stochastic %D was 74.17%. Additionally, its Average True Range was 0.08.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 65.97%, which indicates a significant increase from 65.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.35% in the past 14 days, which was lower than the 63.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0711, while its 200-day Moving Average is $1.2508. However, in the short run, Immunic Inc’s stock first resistance to watch stands at $1.3367. Second resistance stands at $1.4233. The third major resistance level sits at $1.4967. If the price goes on to break the first support level at $1.1767, it is likely to go to the next support level at $1.1033. Should the price break the second support level, the third support level stands at $1.0167.
Immunic Inc (NASDAQ: IMUX) Key Stats
There are currently 90,079K shares outstanding in the company with a market cap of 112.60 million. Presently, the company’s annual sales total 0 K according to its annual income of -93,610 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -24,370 K.
